Abstract:We report the synthesis, characterization, anti-cancer activity and mechanism of a novel water-soluble Cu(II) complex with salicylidene carbohydrazide ligand and o-phenanthroline as co-ligand. The synthesized complex ( 1 ) was characterized by FT-IR, EPR, electronic spectra as well as single crystal X-ray diffraction. This compound was found to be paramagnetic from EPR spectra and X-ray crystallography revealed that the molecule crystallized in an orthorhombic crystal system. The crystal lattice was asymmetric containing two distinct binuclear copper complexes containing the Schiff base as the major ligand, o-phenanthroline as a co-ligand and two nitrate anions, and two water molecules. The Cu(II) in the first site coordinated to the enolised ligand comprising enolate O-, phenolate O - , and the imine N and N,N from o -phen. The major part of this complex exists as Cu(II) coordinated to two H 2 O molecules at the second site and nitrate acted as the counter anion. However, a smaller portion of the complex exists where Cu(II) is coordinated to NO 3 - and H 2 O, and the remaining water molecule acted as lattice water. It was tested for DNA binding and cleavage properties which revealed that it binds in an intercalative mode to CT DNA with K b value of 1.25 × 10 4 M -1 . Further, cleavage studies reveal the complex has potential for efficient DNA cleavage in both oxidative and hydrolytic condition. It was able to enhance the rate of cleavage by (2.8 × 10 8 ) times. The complex shows good cytotoxicity on breast cancer monolayer (2D) as well as spheroids (3D) systems. The IC 50 values for MDA-MB-231 and MCF-7 monolayer culture was calculated as 1.86 ± 0.17μM and 2.22 ± 0.08 μM respectively and in (3D) spheroids of MDA-MB-231 cells, the IC 50 value was calculated to be 1.51 ± 0.29 μM. It was observed that the complex has outperformed cisplatin in both breast cancer cell lines. The cells treated with complex 1 underwent severe DNA damage, increased oxidative stress and cell cycle arrest which finally led to programmed cell death or apoptosis in triple negative breast cancer cells through intrinsic pathway.

A novel chiral oxazoline copper(II)-based complex inhibits ovarian cancer growth in vitro and vivo by regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factors

Syntheses, crystal structures of copper (II)-based complexes of sulfonamide derivatives and their anticancer effects through the synergistic effect of anti-angiogenesis, anti-inflammation, pro-apoptosis and cuproptosis

Selective mediation of ovarian cancer SKOV3 cells death by pristine carbon quantum dots/Cu2O composite through targeting matrix metalloproteinases, angiogenic cytokines and cytoskeleton

A quinoline-2-thione derivative as a novel chemotherapy drug candidate displays anti-tumor activity in vitro and in vivo

Copper-Plumbagin Complex Produces Potent Anticancer Effects by Depolymerizing Microtubules and Inducing Reactive Oxygen Species and DNA Damage

A novel water-soluble Cu(II) gluconate complex inhibits cancer cell growth by triggering apoptosis and ferroptosis related mechanisms

A copper(II)-based complex from mangrove endophytic fungus Fusarium proliferatum inhibits ovarian cancer in vitro via VEGF/VEGFR2 pathways and apoptosis factors

Biological evaluation of optically pure chiral binuclear copper(ii) complexes based on a rosin derivative as highly potential anticancer agents.

Optically pure chiral copper(II) complexes of rosin derivative as attractive anticancer agents with potential anti-metastatic and anti-angiogenic activities.

Synthesis, Characterization and Anti-ovarian Cancer Activities of Novel Biphenyl-NHC-Gold(I) Complexes

A novel copper(II) complex with salicylidene carbohydrazide ligand that promotes oxidative stress and apoptosis in triple negative breast cancer cells

Dinuclear copper(II) complexes with bridging a bis(chalcone) ligand reveal considerable in vitro cytotoxicity on human cancer cells and enhanced selectivity

Investigating Isoquinoline Derivatives for Inhibition of Inhibitor of Apoptosis Proteins for Ovarian Cancer Treatment.

Chelerythrine induces apoptosis and ferroptosis through Nrf2 in ovarian cancer cells

α3 integrin-binding peptide-functionalized polymersomes loaded with volasertib for dually-targeted molecular therapy for ovarian cancer

Novel quercetin encapsulated chitosan functionalized copper oxide nanoparticles as anti-breast cancer agent via regulating p53 in rat model

Oxyresveratrol Enhances the Anti-Cancer Effect of Cisplatin against Epithelial Ovarian Cancer Cells through Suppressing the Activation of Protein Kinase B (AKT)

Chiral Copper(ii) Complex Based on Natural Product Rosin Derivative As Promising Antitumour Agent.

A novel synthesized cyclohexane-hydroxytyrosol derivative suppresses ovarian cancer cell growth through inducing ROS and blocking autophagic flux

Thiophenol-formaldehyde triazole causes apoptosis induction in ovary cancer cells and prevents tumor growth formation in mice model

Ursolic Acid Inhibits Glycolysis of Ovarian Cancer via KLF5/PI3K/AKT Signaling Pathway